Jade Biosciences Inc.
JBIO | NASDAQ
$13.70
-$0.36 (-2.56%)
Nov 2, 2026, 11:28 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 107.25M | 55.09M | 88.44M | 50.11M | 220.94M | 44.22M | 33.75M | 31.12M | 31.07M | 9.12M | 23.49M | 32.18M |
Short-Term Investments | 353.96M | 256.21M | 247.72M | 148.8M | n/a | 31.99M | 44.87M | 57.62M | 73.13M | 90.21M | 98.95M | 103.02M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 69K | 69K | 13.62M | 174K | 60K | -1 | -1 | 81K | 81K | 2.6M | 2.28M | 2.24M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 10.05M | 7.22M | n/a | 2.46M | 0 | 845K | 845K | 882K | 452K | 304K | 250K | 567K |
Total Current Assets | 471.25M | 318.52M | 336.16M | 201.36M | 222.98M | 77.37M | 80.12M | 90.61M | 110.76M | 103.24M | 124.23M | 137.6M |
Property-Plant & Equipment | 793K | 847K | n/a | 916K | 924K | 160K | 215K | 273K | 853K | 985K | 902K | 1.03M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 862K | 916K | 13.62M | 1.09M | 984K | 160K | 215K | 354K | 934K | 3.58M | 3.19M | 3.27M |
Total Assets | 472.11M | 319.43M | 349.78M | 202.45M | 223.97M | 77.53M | 80.33M | 90.96M | 111.69M | 106.82M | 127.42M | 140.88M |
Account Payables | 6.58M | 3.98M | 2.15M | 1.35M | 7.59M | 69K | 224K | 908K | 4.18M | 3.31M | 2.4M | 3.5M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | 312K | 417K | 459K | 475K | 445K | 420K | 451K |
Other Current Liabilities | 21.07M | 15.57M | 3.32M | 8.05M | 5.35M | 429K | 319K | 5M | 9.7M | 10.43M | 10.45M | 8.12M |
Total Current Liabilities | 31.57M | 22.29M | 16.54M | 22.36M | 21.62M | 2.42M | 3.83M | 10.32M | 17.02M | 15.52M | 17.64M | 14.73M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 70K | 70K | 70K | 70K | 70K | 70K | 70K |
Total Long-Term Liabilities | 628K | 679K | 724K | 747K | 792K | 70K | 70K | 151K | 276K | 399K | 325K | 428K |
Total Liabilities | 32.2M | 22.97M | 17.26M | 23.1M | 22.41M | 2.49M | 3.9M | 10.47M | 17.3M | 15.92M | 17.96M | 15.15M |
Total Debt | 628K | 679K | 724K | 747K | 792K | 312K | 417K | 540K | 681K | 774K | 675K | 809K |
Book Value | 439.92M | 296.46M | 332.52M | 179.35M | 201.56M | 75.05M | 76.43M | 80.49M | 94.4M | 90.9M | 109.46M | 125.72M |
Book Value Per Share | 7.21 | 5.13 | 6.74 | 4.53 | 7.09 | 90.62 | 92.30 | 25.51 | 114.90 | 114.46 | 138.33 | 159.20 |
Common Stock | 6K | 5K | 5K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K |
Retained Earnings | -270.52M | -214.76M | -174.39M | -142.46M | -117.28M | -235.57M | -233.05M | -227.62M | -211.39M | -186.61M | -163.42M | -143.01M |
Comprehensive Income | -660K | -342K | 129K | 29K | -24K | 50K | 105K | 224K | -83K | -33K | 237K | -195K |
Shareholders Equity | 439.92M | 296.46M | 332.52M | 179.35M | 201.56M | 75.05M | 76.43M | 80.49M | 94.4M | 90.9M | 109.46M | 125.72M |
Total Investments | 353.96M | 256.21M | 247.72M | 148.8M | n/a | 31.99M | 44.87M | 57.62M | 73.13M | 90.21M | 98.95M | 103.02M |
Add to Watchlist
Select watchlists to add or remove JBIO